Six HIMSS EMRAM Stage 6 Hospitals Awarded at HIMSS Turkey Educational Conference & Exhibition

HIMSS Europe20 - 21 March 2015, Antalya, Turkey.
Six Turkish hospitals will be awarded the prestigious Stage 6 EMRAM award for demonstrating outstanding levels of IT implementation ensuring superior healthcare services and much increased patient safety.

The awards will be presented at the second HIMSS Turkey Educational Conference & Exhibition, which opens its doors in Antalya. The conference, a joint initiative between the Turkish Ministry of Health and HIMSS Europe, is the second in a series of five conferences. The conferences will showcase the results of the Turkish EMRAM data collection, which HIMSS is collecting on behalf of the Turkish Ministry of Health to have all 850 public Turkish Hospitals in the HIMSS Analytics database by 2019.

The six HIMSS EMRAM (EMR Adoption Model) Stage 6 hospitals to be awarded are:

  • Tirebolu Devlet Hastanesi, Giresun.
  • Dr. Suat Seren Göğüs Hastalıkları ve Cerrahisi Eğitim ve Araştırma Hastanesi, İzmir
  • Meslek Hastalıkları Hastanesi, Ankara
  • Bandırma Devlet Hastanesi, Balıkesir
  • Fizik Tedavi ve Rehabilitasyon Hastanesi, Bolu
  • Katip Çelebi Üniversitesi Atatürk Eğitim ve Araştırma Hastanesi, İzmir

Dr. Yilmaz Salman, Head Doctor, from Tirebolu Devlet Hastanesi, one of the hospitals that has reached Stage 6 said: "Our IT systems are helping us to coordinate much of our work and keep track of our patient medical and financial information and coordinate between our departments, with HIMSS EMRAM stage 6 we are able to put new goals such as medical decision support system usage in our system. We will continue working to demonstrate a more elaborated system and HIMSS stage 6 acknowledgments which will encourage us even to do more."

The HIMSS Turkey conference takes place March 20 & 21, 2015 at the Titanic Deluxe Belek Hotel in Antalya. The main themes of the conference are public private partnership projects, healthcare IT and mobility, standards in interoperability, patient involvement, personlised medicine and genomics.

H. Stephen Lieber, President and CEO of HIMSS, said: "Turkey is fast becoming a leading figure in Europe in the transformation of health care through information technology. With six new Stage 6 hospitals recognised this year and five identified last year, Turkey now has 11 'flagship' hospitals in terms of EMR adoption. In absolute numbers Turkey now has the third highest share of Stage 6/7 hospitals in Europe trailing only Spain and the Netherlands. This average and the high number of Stage 6 Award recipients brings Turkey in a league with the top EMRAM countries in Europe. I am proud to celebrate this great accomplishment with those who have driven the country to this strong leadership position."

For further information, please visit:
http://www.himssturkey.org

About HIMSS
HIMSS is a global, cause-based, not-for-profit organization focused on better health through information technology (IT). HIMSS leads efforts to optimize health engagements and care outcomes using information technology.

HIMSS is a part of HIMSS WorldWide, a cause-based, global enterprise producing health IT thought leadership, education, events, market research and media services around the world. Founded in 1961, HIMSS WorldWide encompasses more than 52,000 individuals, of which more than two-thirds work in healthcare provider, governmental and not-for-profit organizations across the globe, plus over 600 corporations and 250 not-for-profit partner organizations, that share this cause. HIMSS WorldWide, headquartered in Chicago, serves the global health IT community with additional offices in the United States, Europe, and Asia.

Most Popular Now

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

A Novel AI-Based Method Reveals How Cell…

Researchers from Tel Aviv University have developed an innovative method that can help to understand better how cells behave in changing biological environments, such as those found within a cancerous...